Response Biomedical Q3 FY15: net income $729K; diluted EPS $0.07

Key figures from this report

These are the numbers Response Biomedical reported for Q3 FY15, the quarter ended Sep 30, 2015, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income$729KAgainst −$1.1M in Q3 FY1410-Q income statement, on EDGAR
2. Diluted EPS$0.07Against −$0.14 in Q3 FY1410-Q income statement, on EDGAR
3. Cash and cash equivalents$2.9M+68% from $1.7M in Q3 FY1410-Q balance sheet, on EDGAR
4. Cash from operations$1.7MAgainst −$750K in Q3 FY1410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters